Here's the argument: Americans pay loads for drugs. That motivates and funds pharmaceutical companies' research and development for better drugs. The fear is that if you lower the cost of drugs you might hurt overall innovation.
Today on the show, we speak with a health economist who argues that's not always true. In fact, she says there are a bunch of policies that could help bring down drug prices without stifling innovation.
Music by Drop Electric. Find us: Twitter / Facebook / Newsletter.
Subscribe to our show on Apple Podcasts, Spotify, Pocket Casts and NPR One.
For sponsor-free episodes of The Indicator from Planet Money, subscribe to Planet Money+ via Apple Podcasts or at plus.npr.org.
2024-12-26 08:522157 view
2024-12-26 08:45128 view
2024-12-26 08:202360 view
2024-12-26 08:13218 view
2024-12-26 07:56148 view
HONG KONG (AP) — Asian stocks were mixed on Wednesday after U.S. indexes drifted lower on Tuesday ah
Colorado football coach Deion Sanders ripped the 8 p.m. local time kickoff set by ESPN for his team’
SAN FRANCISCO (AP) — The Internal Revenue Service says Microsoft owes the U.S. Treasury $28.9 billio
